Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement

INTRODUCTION: Hydroxyethyl starch (HES) is a commonly used colloid in critically ill patients. However, its safety has been questioned in recent studies and meta-analyses. METHODS: We re-evaluated prospective randomised controlled trials (RCT) from four meta-analyses published in 2013 that compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Meybohm, Patrick, Aken, Hugo Van, Gasperi, Andrea De, Hert, Stefan De, Rocca, Giorgio Della, Girbes, Armand RJ, Gombotz, Hans, Guidet, Bertrand, Hasibeder, Walter, Hollmann, Markus W, Ince, Can, Jacob, Matthias, Kranke, Peter, Kozek-Langenecker, Sibylle, Loer, Stephan Alexander, Martin, Claude, Siegemund, Martin, Wunder, Christian, Zacharowski, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056523/
https://www.ncbi.nlm.nih.gov/pubmed/23890518
http://dx.doi.org/10.1186/cc12845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056523/
https://www.ncbi.nlm.nih.gov/pubmed/23890518
http://dx.doi.org/10.1186/cc12845

Ejemplares similares